Faculty profile

Andrew McPartlin

Back to faculty

Assistant ProfessorDepartment of Radiation OncologyUniversity of Toronto

Andrew McPartlin

Assistant Professor

Department of Radiation Oncology

Temerty Faculty of Medicine

University of Toronto

Toronto, Ontario, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
29 publications in the last five years, latest in 2026.
Senior (last) author on 2 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

197

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Roles and appointments

UTDRO Associate Director, Radiation Oncology Research Residency

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Toronto profile.

Latest papers

Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck Cancer.
Journal of medical systems · 2026
Nomogram for Risk-Adaptive Estimation of the Locoregional Control Benefit Following Postoperative Radiation Therapy for Pathologic N0 Oral Cavity Cancer: A Retrospective Analysis.
International journal of radiation oncology, biology, physics · 2026
Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.
Oral oncology · 2026

All 32 publications

Latest funding

The TITRATE (Tailored Intensity of Treatment with Radio(chemo)therapy After Timely Evaluation) study: Toward personalized de-escalated multimodal therapy for oropharynx cancer
CIHR · 2025 · Co-investigator
$1,071,000

All 1 grants and awards

32 publications.

Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck Cancer.

Moharrami M, Watson E, Huang SH, Madathil S, Kim J, McPartlin A, Malik NH, Singhal S, Hahn E, Waldron J, Bratman S, de Almeida J, Yao C, Hope A, Quinonez C, Glogauer M, Hosni A

Journal of medical systems20262 citations

DOI: 10.1007/s10916-026-02359-4 PMID: 41801474

Nomogram for Risk-Adaptive Estimation of the Locoregional Control Benefit Following Postoperative Radiation Therapy for Pathologic N0 Oral Cavity Cancer: A Retrospective Analysis.

Gau M, Su J, Huang SH, Alfaraj FA, Olson R, Marta GN, Kowalski LP, Kohler HF, de Matos LL, Moraes FY, Xu W, Sanz-Garcia E, Hahn E, Kim JJ, McPartlin A, O'Sullivan B, Tsai CJ, Waldron J, Prisman E, Irish JC, Yao CMKL, de Almeida JR, Goldstein DP, Hope A, Hosni A

International journal of radiation oncology, biology, physics20261 citationsOpen Access

DOI: 10.1016/j.ijrobp.2025.09.011 PMID: 40972905

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Ly S, Rühle A, Bratman S, Cho J, Hosni A, Hahn E, Kim J, McPartlin A, Ringash J, O'Sullivan B, Tsai CJ, Waldron J, Goldstein D, Sanz-Garcia E, Spreafico A, Su J, Tong L, Weinreb I, Huang SH, Hope A

Oral oncology20261 citations

DOI: 10.1016/j.oraloncology.2026.108006 PMID: 42127862

Refining adjuvant radiation therapy decision using a nomogram in major salivary gland carcinoma.

Gau M, Su J, Huang SH, Alfaraj FA, Souied O, Mierzwa ML, Marta GN, Kowalski LP, Moraes FY, Xu W, Bayley A, Hahn E, Kim JJ, McPartlin A, O'Sullivan B, Hope A, Tsai CJ, Malik N, Waldron J, Bratman SV, Javed H, de Almeida JR, Yao CMKL, Hosni A

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology20261 citations

DOI: 10.1016/j.radonc.2026.111528 PMID: 42001963

Prevalence and Prognostic Value of Individual T4-Defining Radiologic Features in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

Johari MH, Rühle A, Su J, O'Sullivan B, Yu E, Waldron JN, McPartlin A, Bayley A, Bratman SV, Sanz-Garcia E, Spreafico A, de Almeida J, Hahn E, Hope A, Hosni A, Kim J, Malik N, Xu W, Bartlett E, Huang SH

International journal of radiation oncology, biology, physics20261 citations

DOI: 10.1016/j.ijrobp.2025.12.032 PMID: 41448500

Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT.

Rühle A, Subramani R, Su J, O'Sullivan B, Waldron JN, Hope A, Bayley A, McPartlin A, Malik N, Bratman SV, Hosni A, Kim J, Witterick I, de Almeida JR, Yao C, Spreafico A, Tsai CJ, Tong L, Xu W, Huang SH, Hahn E

The Laryngoscope20261 citationsOpen Access

DOI: 10.1002/lary.70424 PMID: 41654325

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Rühle A, Sanz-Garcia E, Su J, O'Sullivan B, Waldron JN, Spreafico A, Siu L, Eng L, McPartlin A, Bayley A, Bratman SV, Hahn E, Hope A, Hosni A, Malik N, Tsai J, de Almeida J, Xu W, Kim J, Huang SH

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111769 PMID: 42697275

Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.

Chelvarajah RC, Chee LYS, Su J, O'Sullivan B, Yao CMKL, Sanz-Garcia E, Smith SM, Weinreb I, Bratman S, Cho BCJ, Hahn E, Hope A, Hosni A, Kim J, McPartlin A, Malik N, Tsai CJ, de Almeida J, Spreafico A, Tong L, Huang SH, Waldron JN

Head & neck2026Open Access

DOI: 10.1002/hed.70230 PMID: 41816946

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.

Penny L, Stutheit-Zhao EY, Michels BE, Rosing F, Zhao Z, Zheng Y, Zou J, Huang SH, Carlton J, McPartlin A, de Almeida JR, Goldstein D, Hope A, Hosni A, Kim J, Liu FF, Tsai CJ, Waldron JN, Spreafico A, Sanz-Garcia E, Siu LL, Waterboer T, Liu G, Bratman SV

International journal of cancer2026Open Access

DOI: 10.1002/ijc.70619 PMID: 42380047

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

Mathew JM, Bacon H, Winter J, Bernstein J, Liu ZA, Kong V, Dang J, Wang K, Chung P, Bayley A, Berlin A, Catton C, Gutierrez E, Mesci A, McPartlin A, Raman S, Alibhai S, Taylor E, Warde P, Glicksman RM

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2026

DOI: 10.1016/j.radonc.2026.111614 PMID: 42177994

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Andrew McPartlin

Research

Latest papers

Latest funding

Machine Learning Models for Individualized Osteoradionecrosis Risk Prediction in Head and Neck Cancer.

Nomogram for Risk-Adaptive Estimation of the Locoregional Control Benefit Following Postoperative Radiation Therapy for Pathologic N0 Oral Cavity Cancer: A Retrospective Analysis.

Impact of metastasis-directed therapy for metachronous thoracic metastases following definitive (chemo)radiotherapy in p16-positive head and neck squamous cell carcinoma.

Refining adjuvant radiation therapy decision using a nomogram in major salivary gland carcinoma.

Prevalence and Prognostic Value of Individual T4-Defining Radiologic Features in Human Papillomavirus-Positive Oropharyngeal Carcinoma.

Prognostic Value of Impaired Vocal Cord Mobility in T2N0 Glottic Cancer Treated With IMRT.

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Disease Site-Specific Outcomes in p16-Positive Non-Oropharyngeal Mucosal Head and Neck Cancer.

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in&#xa0;Oropharyngeal Cancer.

Moderate hypofractionated boost to the prostate with pelvic radiotherapy in high-risk prostate cancer (MOB-RT) - a phase 2 study: acute safety and quality of life outcomes.

The TITRATE (Tailored Intensity of Treatment with Radio(chemo)therapy After Timely Evaluation) study: Toward personalized de-escalated multimodal therapy for oropharynx cancer

Frequent collaborators

Ali Hosni

Andrew Hope

John Kim

Scott Bratman

Ezra Hahn

Brian O'Sullivan

Anna Spreafico

John Waldron

John de Almeida

C. Tsai

Enrique Sanz Garcia

Andrew Bayley

Wei Xu

Christopher Yao

Jolie Ringash

Alejandro Berlin

Nauman Malik

Chiaojung Tsai

Peter Chung

Charles Catton

Aruz Mesci

David Goldstein

Eugene Yu

Padraig Warde

Lillian Siu

Eric Bartlett

Osama Souied

Tara Rosewall

Eric Monteiro

Sharon Tzelnick

HPV Serology and Circulating Viral DNA for Detection, Genotyping, and Measurement of Disease Burden in Oropharyngeal Cancer.